About Us

We are Bionime USA

Diabetes is a major global health threat, with 11.5% of global healthcare spending allocated to diabetes care, amounting to $966 billion annually. In many countries, 70%-80% of diabetes care expenses are spent on managing complications, so “blood glucose management” is the only way to prevent these complications.

Founded in 2003, Bionime focuses on the research, design, manufacturing, and marketing “ Blood Glucose Management Systems” Our products include measuring devices for “Personal home use” and “Professional use” such as Blood Glucose Meters (BGM), Continuous Glucose Monitoring Systems (CGM), and Point-of-Care Testing (POCT). We also offer a cloud-based blood glucose management system under our self-branded “RIGHTEST” utilizing “IoT digital solutions,” which connects “medical information from the product side” with “customer service and marketing information from the market side” to create a “human-centered” “blood glucose management ecosystem.”